{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T07:45:22Z","timestamp":1791877522031,"version":"4.3.4"},"reference-count":20,"publisher":"Wiley","license":[{"start":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T00:00:00Z","timestamp":1791763200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"},{"start":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T00:00:00Z","timestamp":1791763200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J. pediatr. gastroenterol. nutr."],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>Microscopic colitis (MC) is a histological inflammatory disease of the colon, commonly diagnosed in adults and known to be associated with autoimmune conditions. Clinical presentation and treatment outcomes in pediatrics are not well described. The aim of the current study was to describe pediatric MC cases encountered at a single center over a 13\u2010year period.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We performed a retrospective chart review of patients aged 18 years and younger (inclusive) evaluated in our health system between 2013 and 2025 for MC.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Thirty\u2010five patients (80% female) with an average age of 14.2 years at MC diagnosis were included. Presenting symptoms were chronic diarrhea, abdominal pain, and weight loss. Histologically, most patients had lymphocytic colitis (74%), and seven patients (20%) had concurrent celiac disease (CeD). At diagnosis, no patients had elevated systemic inflammatory markers and fecal calprotectin (tested in 26% of patients) was elevated in 66%. The most prescribed treatments included Budesonide (77%) and aminosalicylates (34%). Two patients required biologic therapy including Vedolizumab, Ustekinumab, and Adalimumab. A clinical subgroup emerged who showed complete symptomatic response to Budesonide without additional therapy (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u20098), and four patients in this group had CeD.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>This study adds to the limited pediatric MC literature, including two cases requiring biologic therapy. Fecal calprotectin is presently underutilized but, when tested, was not reliably elevated in the active disease state. Like adults, Budesonide was the most prescribed therapy for pediatric MC and may represent an important first line treatment option due to select patients exhibiting complete symptomatic response.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1002\/jpn3.70601","type":"journal-article","created":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T06:50:44Z","timestamp":1791874244000},"source":"Crossref","is-referenced-by-count":0,"title":["Clinical characteristics and treatment outcomes in pediatric microscopic colitis: A retrospective 13\u2010year experience"],"prefix":"10.1002","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0691-5773","authenticated-orcid":false,"given":"Stephanie","family":"Camhi","sequence":"first","affiliation":[{"name":"Mass General Brigham for Children Division of Pediatric Gastroenterology and Nutrition Boston Massachusetts USA"},{"name":"Center for Celiac Research and Treatment Mass General Brigham for Children Boston Massachusetts USA"},{"name":"Harvard Medical School Boston Massachusetts USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-6401-917X","authenticated-orcid":false,"given":"Kamryn","family":"Jebb","sequence":"additional","affiliation":[{"name":"Harvard Medical School Boston Massachusetts USA"},{"name":"Mass General Brigham for Children Pediatric Residency Program Boston Massachusetts USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kendall","family":"Kleinman","sequence":"additional","affiliation":[{"name":"Center for Celiac Research and Treatment Mass General Brigham for Children Boston Massachusetts USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victoria","family":"Kenyon","sequence":"additional","affiliation":[{"name":"Center for Celiac Research and Treatment Mass General Brigham for Children Boston Massachusetts USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4322-9564","authenticated-orcid":false,"given":"Victoria M.","family":"Martin","sequence":"additional","affiliation":[{"name":"Mass General Brigham for Children Division of Pediatric Gastroenterology and Nutrition Boston Massachusetts USA"},{"name":"Harvard Medical School Boston Massachusetts USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5955-5102","authenticated-orcid":false,"given":"Maureen M.","family":"Leonard","sequence":"additional","affiliation":[{"name":"Mass General Brigham for Children Division of Pediatric Gastroenterology and Nutrition Boston Massachusetts USA"},{"name":"Center for Celiac Research and Treatment Mass General Brigham for Children Boston Massachusetts USA"},{"name":"Harvard Medical School Boston Massachusetts USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2026,10,12]]},"reference":[{"issue":"1","key":"e_1_2_8_2_1","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1038\/s41572-021-00281-2","article-title":"Microscopic colitis","volume":"7","year":"2021","journal-title":"Nat Rev Dis Primer"},{"issue":"2","key":"e_1_2_8_3_1","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1177\/10935266231215117","article-title":"Clinicopathologic characterization of lymphocytic colitis in the pediatric population","volume":"27","author":"Gonz\u00e1lez IA","year":"2024","journal-title":"Pediatr Dev Pathol"},{"issue":"3","key":"e_1_2_8_4_1","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1007\/s40272-022-00504-3","article-title":"Diagnosis and management of microscopic colitis in pediatric patients","volume":"24","author":"Khushal S","year":"2022","journal-title":"Pediatr Drugs"},{"issue":"7","key":"e_1_2_8_5_1","doi-asserted-by":"crossref","first-page":"1996","DOI":"10.1007\/s10620-009-0964-4","article-title":"Microscopic colitis in children","volume":"55","author":"El\u2010Matary W","year":"2010","journal-title":"Dig Dis Sci"},{"key":"e_1_2_8_6_1","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.humpath.2020.09.011","article-title":"Lymphocytic and collagenous colitis in children and adolescents: comprehensive clinicopathologic analysis with long\u2010term follow\u2010up","volume":"106","author":"Windon AL","year":"2020","journal-title":"Hum Pathol"},{"issue":"1","key":"e_1_2_8_7_1","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1053\/j.gastro.2015.11.008","article-title":"American Gastroenterological Association Institute guideline on the medical management of microscopic colitis","volume":"150","author":"Nguyen GC","year":"2016","journal-title":"Gastroenterology"},{"issue":"1","key":"e_1_2_8_8_1","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1177\/2050640620951905","article-title":"European guidelines on microscopic colitis: United European Gastroenterology and European Microscopic Colitis Group statements and recommendations","volume":"9","author":"Miehlke S","year":"2021","journal-title":"United European Gastroenterol J"},{"issue":"4","key":"e_1_2_8_9_1","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/S2468-1253(19)30048-2","article-title":"Microscopic colitis: pathophysiology and clinical management","volume":"4","author":"Miehlke S","year":"2019","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"5","key":"e_1_2_8_10_1","doi-asserted-by":"crossref","first-page":"2951","DOI":"10.1097\/MS9.0000000000001946","article-title":"Evaluation of non\u2010invasive diagnostic tools for diarrhea: a systematic review of point\u2010of\u2010care tests and biomarkers","volume":"86","author":"Patel HM","year":"2024","journal-title":"Ann Med Surg"},{"issue":"7","key":"e_1_2_8_11_1","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1097\/MEG.0b013e328058ed76","article-title":"Metabolic and inflammatory faecal markers in collagenous colitis","volume":"19","author":"Wildt S","year":"2007","journal-title":"Eur J Gastroenterol Hepatol"},{"issue":"12","key":"e_1_2_8_12_1","doi-asserted-by":"crossref","first-page":"1646","DOI":"10.1016\/j.dld.2019.07.002","article-title":"Usefulness of fecal calprotectin as a biomarker of microscopic colitis in a cohort of patients with chronic watery diarrhoea of functional characteristics","volume":"51","author":"Batista L","year":"2019","journal-title":"Digest Liver Dis"},{"issue":"5","key":"e_1_2_8_13_1","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1016\/j.mayocp.2021.03.022","article-title":"Microscopic colitis: a concise review for clinicians","volume":"96","author":"Tome J","year":"2021","journal-title":"Mayo Clin Proc"},{"issue":"2","key":"e_1_2_8_14_1","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1002\/ueg2.12374","article-title":"Celiac disease and risk of microscopic colitis: a nationwide population\u2010based matched cohort study","volume":"11","author":"Bergman D","year":"2023","journal-title":"Unit Eur Gastroenterol J"},{"issue":"11","key":"e_1_2_8_15_1","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1111\/apt.15246","article-title":"A nationwide cohort study of the incidence of microscopic colitis in Sweden","volume":"49","author":"Bergman D","year":"2019","journal-title":"Aliment Pharmacol Ther"},{"issue":"6","key":"e_1_2_8_16_1","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1038\/modpathol.2012.227","article-title":"Collagenous colitis in children and adolescents: study of 7 cases and literature review","volume":"26","author":"Liu X","year":"2013","journal-title":"Modern Pathol"},{"issue":"1","key":"e_1_2_8_17_1","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1002\/jpn3.70432","article-title":"Microscopic colitis in children: a single\u2010center experience and systematic review","volume":"83","author":"Hern\u00e1ndez D\u00edaz LM","year":"2026","journal-title":"J Pediatr Gastroenterol Nutr"},{"issue":"9","key":"e_1_2_8_18_1","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1016\/j.crohns.2012.05.014","article-title":"Microscopic colitis: current status, present and future challenges","volume":"6","author":"M\u00fcnch A","year":"2012","journal-title":"J Crohn's Colitis"},{"issue":"1","key":"e_1_2_8_19_1","doi-asserted-by":"crossref","first-page":"e47","DOI":"10.1097\/MPG.0000000000002739","article-title":"Vedolizumab for the induction of remission in treatment\u2010refractory microscopic colitis in a pediatric patient","volume":"71","author":"Wenzel AA","year":"2020","journal-title":"J Pediatr Gastroenterol Nutr"},{"issue":"10","key":"e_1_2_8_20_1","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1097\/MEG.0000000000002409","article-title":"Efficacy and safety of biologic therapy in microscopic colitis: systematic review and meta\u2010analysis","volume":"34","author":"Taneja V","year":"2022","journal-title":"Eur J Gastroenterol Hepatol"},{"issue":"8","key":"e_1_2_8_21_1","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1097\/MCG.0000000000001914","article-title":"Efficacy and safety of vedolizumab and tumor necrosis factor inhibitors in the treatment of steroid\u2010refractory microscopic colitis: a systematic review and meta\u2010analysis","volume":"58","author":"El Hage Chehade N","year":"2024","journal-title":"J Clin Gastroenterol"}],"container-title":["Journal of Pediatric Gastroenterology and Nutrition"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/jpn3.70601","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1002\/jpn3.70601","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/jpn3.70601","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T06:50:46Z","timestamp":1791874246000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/jpn3.70601"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,12]]},"references-count":20,"alternative-id":["10.1002\/jpn3.70601"],"URL":"https:\/\/doi.org\/10.1002\/jpn3.70601","archive":["Portico"],"relation":{},"ISSN":["0277-2116","1536-4801"],"issn-type":[{"value":"0277-2116","type":"print"},{"value":"1536-4801","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,12]]},"article-number":"jpn3.70601"}}